235 related articles for article (PubMed ID: 10486157)
21. Myelodysplastic syndromes and acute myeloid leukemia in cats infected with feline leukemia virus clone33 containing a unique long terminal repeat.
Hisasue M; Nagashima N; Nishigaki K; Fukuzawa I; Ura S; Katae H; Tsuchiya R; Yamada T; Hasegawa A; Tsujimoto H
Int J Cancer; 2009 Mar; 124(5):1133-41. PubMed ID: 19035458
[TBL] [Abstract][Full Text] [Related]
22. [Histopathologic diagnosis of bone marrow in leukemia and related disorders].
Kikuchi M; Ohshima K; Kobari S
Rinsho Byori; 1991 Dec; 39(12):1245-9. PubMed ID: 1779461
[TBL] [Abstract][Full Text] [Related]
23. Myeloid malignancies: myelodysplastic syndromes, myeloproliferative disorders, and acute myeloid leukemia.
Wood BL
Clin Lab Med; 2007 Sep; 27(3):551-75, vii. PubMed ID: 17658407
[TBL] [Abstract][Full Text] [Related]
24. Survivin expression, apoptosis and proliferation in chronic myelomonocytic leukemia.
Invernizzi R; Travaglino E; Benatti C; Malcovati L; Della Porta M; Cazzola M; Ascari E
Eur J Haematol; 2006 Jun; 76(6):494-501. PubMed ID: 16529600
[TBL] [Abstract][Full Text] [Related]
25. Dysmyelopoiesis in the cat: a hematological disorder resembling refractory anemia with excess blasts in man.
Baker RJ; Valli VE
Can J Vet Res; 1986 Jan; 50(1):3-6. PubMed ID: 3742354
[TBL] [Abstract][Full Text] [Related]
26. Clonality analysis of various hematopoietic disorders in cats naturally infected with feline leukemia virus.
Hisasue M; Nishigaki K; Katae H; Yuri K; Mizuno T; Fujino Y; Setoguchi A; Hasegawa A; Watari T; Masuda K; Ohno K; Tsujimoto H
J Vet Med Sci; 2000 Oct; 62(10):1059-65. PubMed ID: 11073076
[TBL] [Abstract][Full Text] [Related]
27. [Study on the transformation from myelodysplastic syndromes into acute leukemias].
Shi J; Shao Z; Liu H; Li K; Song L; Zhang Y; Zheng Y; Chen G; Chu Y; He H; Zhao M; He G; Feng B; Hao Y; Yang T; Yang C
Zhonghua Xue Ye Xue Za Zhi; 2001 Jul; 22(7):351-4. PubMed ID: 11877096
[TBL] [Abstract][Full Text] [Related]
28. Bone marrow stromal cell distribution of basic fibroblast growth factor in chronic myeloid disorders.
Yoon SY; Tefferi A; Li CY
Haematologica; 2001 Jan; 86(1):52-7. PubMed ID: 11146571
[TBL] [Abstract][Full Text] [Related]
29. Myelodysplastic changes in a cat with myelomonocytic leukemia.
Raskin RE; Krehbiel JD
J Am Vet Med Assoc; 1985 Jul; 187(2):171-4. PubMed ID: 3861601
[TBL] [Abstract][Full Text] [Related]
30. [Extramedullary initial manifestations of acute myeloid leukemia (AML)].
Schmitt-Gräff A; Wickenhauser C; Kvasnicka HM; Dries V; Thiele J
Pathologe; 2002 Nov; 23(6):397-404. PubMed ID: 12436291
[TBL] [Abstract][Full Text] [Related]
31. Bone marrow colony-forming unit assay in cats with naturally occurring myelodysplastic syndromes.
Nagashima N; Hisasue M; Higashi K; Kano R; Tsujimoto H; Hasegawa A
Int J Hematol; 2001 Jun; 73(4):453-456. PubMed ID: 11503958
[TBL] [Abstract][Full Text] [Related]
32. Evaluation of dysmyelopoiesis in cats: 34 cases (1996-2005).
Weiss DJ
J Am Vet Med Assoc; 2006 Mar; 228(6):893-7. PubMed ID: 16536701
[TBL] [Abstract][Full Text] [Related]
33. Plasma basic fibroblast growth factor and bone marrow fibrosis in clonal myeloproliferative disorders.
Sayinalp N; Cinar H; Uner A; Haznedaroğlu IC; Büyükaşik Y; Göker H; Aksu S; Ozcebe OI; Karakuş S; Kirazli S; Dündar SV
Clin Lab Haematol; 2004 Aug; 26(4):265-8. PubMed ID: 15279663
[TBL] [Abstract][Full Text] [Related]
34. Hematologic abnormalities and outcome of 16 cats with myelodysplastic syndromes.
Hisasue M; Okayama H; Okayama T; Suzuki T; Mizuno T; Fujino Y; Naganobu K; Hasegawa A; Watari T; Matsuki N; Masuda K; Ohno K; Tsujimoto H
J Vet Intern Med; 2001; 15(5):471-7. PubMed ID: 11596735
[TBL] [Abstract][Full Text] [Related]
35. Issues in the pathology of the myelodysplastic syndromes.
Kampmeier P; Anastasi J; Vardiman JW
Hematol Oncol Clin North Am; 1992 Jun; 6(3):501-22. PubMed ID: 1613003
[TBL] [Abstract][Full Text] [Related]
36. Acute myeloblastic leukemia with trilineage myelodysplasia and CD34+ blast cells with abnormal chromatin clumping.
Gil S; Luño E; Rodriguez JA
Haematologica; 1998 Aug; 83(8):750-1. PubMed ID: 9793262
[TBL] [Abstract][Full Text] [Related]
37. Results of imatinib mesylate therapy in patients with refractory or recurrent acute myeloid leukemia, high-risk myelodysplastic syndrome, and myeloproliferative disorders.
Cortes J; Giles F; O'Brien S; Thomas D; Albitar M; Rios MB; Talpaz M; Garcia-Manero G; Faderl S; Letvak L; Salvado A; Kantarjian H
Cancer; 2003 Jun; 97(11):2760-6. PubMed ID: 12767088
[TBL] [Abstract][Full Text] [Related]
38. Biological and clinical relevance of matrix metalloproteinases 2 and 9 in acute myeloid leukaemias and myelodysplastic syndromes.
Travaglino E; Benatti C; Malcovati L; Della Porta MG; Gallì A; Bonetti E; Rosti V; Cazzola M; Invernizzi R
Eur J Haematol; 2008 Mar; 80(3):216-26. PubMed ID: 18081721
[TBL] [Abstract][Full Text] [Related]
39. Transformation of myelodysplastic syndromes into acute myeloid leukemias.
Shi J; Shao ZH; Liu H; Bai J; Cao YR; He GS; Tu MF; Wang XL; Hao YS; Yang TY; Yang CL
Chin Med J (Engl); 2004 Jul; 117(7):963-7. PubMed ID: 15265365
[TBL] [Abstract][Full Text] [Related]
40. Angiogenesis in myelodysplastic syndromes.
Pruneri G; Bertolini F; Soligo D; Carboni N; Cortelezzi A; Ferrucci PF; Buffa R; Lambertenghi-Deliliers G; Pezzella F
Br J Cancer; 1999 Dec; 81(8):1398-401. PubMed ID: 10604739
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
